Cargando…

Therapy of IBS: Is a Low FODMAP Diet the Answer?

Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder with a worldwide prevalence of 11%. It is characterized by abdominal pain and altered bowel habits in the absence of underlying unique pathology. The condition is associated with poor quality of life and high u...

Descripción completa

Detalles Bibliográficos
Autores principales: Manning, Lauren P., Yao, C. K., Biesiekierski, Jessica R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488954/
https://www.ncbi.nlm.nih.gov/pubmed/33110411
http://dx.doi.org/10.3389/fpsyt.2020.00865
_version_ 1783581795495706624
author Manning, Lauren P.
Yao, C. K.
Biesiekierski, Jessica R.
author_facet Manning, Lauren P.
Yao, C. K.
Biesiekierski, Jessica R.
author_sort Manning, Lauren P.
collection PubMed
description Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder with a worldwide prevalence of 11%. It is characterized by abdominal pain and altered bowel habits in the absence of underlying unique pathology. The condition is associated with poor quality of life and high use of healthcare resources required for management. The low FODMAP diet (LFD) is a recognized treatment for symptom management of IBS; however, approximately 30% of patients do not respond. The aim of this review was to understand the effectiveness and application of the LFD compared with other dietary and non-dietary interventions. Ten studies were included, eight of which assessed the LFD against other dietary interventions including traditional dietary advice, modified National Institute for Health and Care Excellence guidelines, a high FODMAP diet, gluten-free diet and Mediterranean diet, generalized dietary advice, probiotics, and a sham diet. Two studies compared a LFD to non-diet interventions of gut directed hypnotherapy or yoga. The findings clearly support the LFD as an effective treatment in IBS, and although it highlights the role for microbiota and current psychosocial state, it remains challenging to identify what combination of treatments may be best to ensure a personalized approach and overall higher response rates to IBS therapy.
format Online
Article
Text
id pubmed-7488954
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74889542020-10-26 Therapy of IBS: Is a Low FODMAP Diet the Answer? Manning, Lauren P. Yao, C. K. Biesiekierski, Jessica R. Front Psychiatry Psychiatry Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder with a worldwide prevalence of 11%. It is characterized by abdominal pain and altered bowel habits in the absence of underlying unique pathology. The condition is associated with poor quality of life and high use of healthcare resources required for management. The low FODMAP diet (LFD) is a recognized treatment for symptom management of IBS; however, approximately 30% of patients do not respond. The aim of this review was to understand the effectiveness and application of the LFD compared with other dietary and non-dietary interventions. Ten studies were included, eight of which assessed the LFD against other dietary interventions including traditional dietary advice, modified National Institute for Health and Care Excellence guidelines, a high FODMAP diet, gluten-free diet and Mediterranean diet, generalized dietary advice, probiotics, and a sham diet. Two studies compared a LFD to non-diet interventions of gut directed hypnotherapy or yoga. The findings clearly support the LFD as an effective treatment in IBS, and although it highlights the role for microbiota and current psychosocial state, it remains challenging to identify what combination of treatments may be best to ensure a personalized approach and overall higher response rates to IBS therapy. Frontiers Media S.A. 2020-08-31 /pmc/articles/PMC7488954/ /pubmed/33110411 http://dx.doi.org/10.3389/fpsyt.2020.00865 Text en Copyright © 2020 Manning, Yao and Biesiekierski http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Manning, Lauren P.
Yao, C. K.
Biesiekierski, Jessica R.
Therapy of IBS: Is a Low FODMAP Diet the Answer?
title Therapy of IBS: Is a Low FODMAP Diet the Answer?
title_full Therapy of IBS: Is a Low FODMAP Diet the Answer?
title_fullStr Therapy of IBS: Is a Low FODMAP Diet the Answer?
title_full_unstemmed Therapy of IBS: Is a Low FODMAP Diet the Answer?
title_short Therapy of IBS: Is a Low FODMAP Diet the Answer?
title_sort therapy of ibs: is a low fodmap diet the answer?
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488954/
https://www.ncbi.nlm.nih.gov/pubmed/33110411
http://dx.doi.org/10.3389/fpsyt.2020.00865
work_keys_str_mv AT manninglaurenp therapyofibsisalowfodmapdiettheanswer
AT yaock therapyofibsisalowfodmapdiettheanswer
AT biesiekierskijessicar therapyofibsisalowfodmapdiettheanswer